GHK-Cu (Copper Peptide)

AHK-Cu vs GHK-Cu

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-312 cited sources

AHK-Cu is alanyl-histidyl-lysine copper; GHK-Cu is glycyl-histidyl-lysine copper. They differ at the first residue — alanine instead of glycine — which makes AHK-Cu slightly larger and more hydrophobic. GHK-Cu occurs naturally in human plasma; AHK-Cu is a synthetic analogue with a much smaller literature.

Key facts

GHK-Cu first residue
Glycine
AHK-Cu first residue
Alanine
Occurs naturally
GHK-Cu only
Marketed mainly for
AHK-Cu: hair
Size of literature
GHK-Cu far larger

One residue, and what it changes

Glycine has a hydrogen side chain; alanine has a methyl group. Swapping one for the other adds a small amount of mass and hydrophobicity without altering the histidine and lysine residues that do most of the copper coordination. The copper binding site is therefore broadly preserved, which is why AHK-Cu behaves as a copper carrier at all.

Only one of them is a human peptide

GHK was isolated from human plasma in 1973 and is a naturally occurring fragment with a documented age-related decline. AHK-Cu is a designed analogue. That distinction matters for any argument that rests on the peptide being something the body already makes — an argument that applies to GHK-Cu and not to AHK-Cu.

Research material referenced

GHK-Cu 100mg — third-party HPLC tested

View — £24.99

Why AHK-Cu appears in hair products

AHK-Cu is more often formulated into hair products, on the basis of early work suggesting effects on follicles. The evidence base is considerably smaller than GHK-Cu's, which is itself limited. The marketing separation between the two is sharper than the evidence separating them.

They are not interchangeable

Findings for one do not transfer to the other. Because most published copper peptide work concerns GHK-Cu, claims made for AHK-Cu products frequently rest on GHK-Cu studies. That substitution is not valid, and it is worth checking which peptide a cited study actually used.

Quick reference

GHK-CuAHK-Cu
SequenceGly-His-LysAla-His-Lys
Occurs in humansYesNo
Discovered / designedIsolated 1973Synthetic analogue
Marketed mainly forSkinHair
Published literatureSubstantialSparse

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically — nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses — including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

  • In vitro fibroblast and keratinocyte gene-expression studies
  • ECM turnover assays (collagen, elastin, decorin, MMP profiling)
  • Wound-healing scratch assays in cell culture models
  • Antioxidant-mechanism studies (copper redox modulation)
  • Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

  • Store lyophilised vial at 2–8 °C, protected from light
  • Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
  • Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
  • Aliquot reconstituted solution for freeze/thaw minimisation
  • Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex — keep them separate.

Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

  • Is GHK-Cu the same as copper peptide?
  • What does GHK-Cu do in research studies?
  • Is GHK-Cu safe for topical formulation research?
  • What concentration of GHK-Cu is used in cell culture?
  • How is GHK-Cu different from GHK alone?

Frequently asked questions

What is the difference between AHK-Cu and GHK-Cu?
The first amino acid. GHK-Cu begins with glycine, AHK-Cu with alanine. GHK-Cu occurs naturally in human plasma; AHK-Cu is a synthetic analogue with a much smaller evidence base.
Is AHK-Cu better than GHK-Cu?
No comparison supports that. AHK-Cu is more often marketed for hair, but its published literature is considerably thinner and no head-to-head study exists.
Can AHK-Cu studies be applied to GHK-Cu?
No, and the reverse substitution is more common — AHK-Cu products citing GHK-Cu research. Check which peptide a cited study actually used.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

JM

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.